🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cerus stock PT raised to $4 at Cantor Fitzgerald, citing strong 1Q revenue

Published 03/05/2024, 16:28
CERS
-

On Friday, Cerus (NASDAQ:CERS) Corporation (NASDAQ:CERS) received a positive outlook from Cantor Fitzgerald, as the firm raised its 12-month price target to $4.00 from the previous $3.00, while reaffirming an Overweight rating on the stock. The adjustment follows Cerus's announcement of its first-quarter earnings for 2024, which demonstrated a year-over-year revenue increase of approximately 13%.

The company reported first-quarter revenue of $43.4 million, which was slightly above the FactSet consensus of $43.2 million but fell short of Cantor's projection of $44.8 million. This revenue growth was attributed to a resurgence in routine ordering patterns among U.S. customers, with total product revenue climbing roughly 24% year-over-year to $38.4 million.

In addition to the solid quarterly performance, Cerus confirmed its revenue guidance for the full year of 2024, projecting product revenues to be in the range of $172-175 million. The company also anticipates that revenue from its INTERCEPT Fibrinogen Complex will contribute between $8-10 million for the fiscal year.

Cerus's financial outlook for 2024 remains robust, as the company expects to achieve adjusted EBITDA breakeven within the year. This outlook is based on the company's recent performance and projections, signaling a return to growth and increasing profitability. The reaffirmed Overweight rating by Cantor Fitzgerald reflects confidence in Cerus's financial trajectory and market position.

InvestingPro Insights

Following the positive outlook from Cantor Fitzgerald, current InvestingPro data provides further context on Cerus Corporation's financial health. The company's market capitalization stands at $325.41 million, and while the stock is trading at a high Price / Book multiple of 6.59, this could reflect the market's expectations for future growth. Cerus's revenue for the last twelve months as of Q1 2024 was reported at $163.76 million, with a solid revenue growth of 5.26%. This growth is further highlighted by a substantial quarterly increase of 23.86% in Q1 2024, aligning with the patterns observed in the company's earnings report.

InvestingPro Tips indicate that despite analysts not expecting Cerus to be profitable this year, the company's liquid assets do indeed exceed short-term obligations, suggesting a degree of financial stability. Moreover, Cerus operates with a moderate level of debt, which may provide some reassurance to investors concerned about financial risk. For readers looking to delve deeper into the company's financial details, there are additional InvestingPro Tips available, which can be accessed through the dedicated page for Cerus Corporation at InvestingPro. To enhance your investing strategy with these insights, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.